Nazarov, V. D., Lapin, S. V., Dobronravov, V. A., Smirnov, K. A., Mayer, D. A., Muzhetskaya, T. O., & Totolian, A. A. (2018). CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI.
Style de citation Chicago (17e éd.)Nazarov, V. D., S. V. Lapin, V. A. Dobronravov, K. A. Smirnov, D. A. Mayer, T. O. Muzhetskaya, et A. A. Totolian. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI, 2018.
Style de citation MLA (8e éd.)Nazarov, V. D., et al. CIRCULATING ANTIBODIES TO ERYTHROPOIETIN ARE ASSOCIATED WITH LOWER EFFICACY OF RECOMBINANT EPOETIN TREATMENT IN PATIENTS UNDERGOING HAEMODIALYSIS. SPb RAACI, 2018.